135 related articles for article (PubMed ID: 12493586)
1. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.
Le Bricon T; Bengoufa D; Benlakehal M; Bousquet B; Erlich D
Clin Biochem; 2002 Oct; 35(7):565-7. PubMed ID: 12493586
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of measurement of free light chains].
Matsuda M
Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770
[TBL] [Abstract][Full Text] [Related]
3. The FLC dimer with lambda type may false-migrate to the position of "albumin" band by urine protein electrophoresis on Sebia agarose gel-based detection system.
Chen C; Chen P; Fang X
J Clin Lab Anal; 2019 Feb; 33(2):e22658. PubMed ID: 30152095
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Free Immunoglobulin Light Chains in Urine.
Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma.
Caillon H; Avet-Loiseau H; Attal M; Moreau P; Decaux O; Dejoie T
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e228-e237. PubMed ID: 30799237
[TBL] [Abstract][Full Text] [Related]
7. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
[TBL] [Abstract][Full Text] [Related]
9. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of hidden free light chains by immunosubtraction.
Thelen MH; van Bezu J; Kok A; Schutgens RB
Clin Chem; 2002 Nov; 48(11):2044-5. PubMed ID: 12406991
[No Abstract] [Full Text] [Related]
12. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Dejoie T; Corre J; Caillon H; Hulin C; Perrot A; Caillot D; Boyle E; Chretien ML; Fontan J; Belhadj K; Brechignac S; Decaux O; Voillat L; Rodon P; Fitoussi O; Araujo C; Benboubker L; Fontan C; Tiab M; Godmer P; Luycx O; Allangba O; Pignon JM; Fuzibet JG; Legros L; Stoppa AM; Dib M; Pegourie B; Orsini-Piocelle F; Karlin L; Arnulf B; Roussel M; Garderet L; Mohty M; Meuleman N; Doyen C; Lenain P; Macro M; Leleu X; Facon T; Moreau P; Attal M; Avet-Loiseau H
Blood; 2016 Dec; 128(25):2941-2948. PubMed ID: 27729323
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
Lutteri L; Aldenhoff MC; Cavalier E
Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
[TBL] [Abstract][Full Text] [Related]
16. Questionable role of free light chain assay ratio to determine stringent complete remission in multiple myeloma patients.
Kröger N; Asenova S; Gerritzen A; Bacher U; Zander A
Blood; 2010 Apr; 115(16):3413-4; author reply 3414-5. PubMed ID: 20413663
[No Abstract] [Full Text] [Related]
17. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
Mahmood S; Wassef NL; Salter SJ; Sachchithanantham S; Lane T; Foard D; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Am J Clin Pathol; 2016 Jul; 146(1):78-85. PubMed ID: 27353767
[TBL] [Abstract][Full Text] [Related]
19. Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma.
Le Bricon T; Erlich D; Bengoufa D; Dussaucy M; Garnier JP; Bousquet B
Clin Chem; 1998 Jun; 44(6 Pt 1):1191-7. PubMed ID: 9625042
[TBL] [Abstract][Full Text] [Related]
20. [Free light chains assay: Indications and methods].
Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
